Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study

Abstract

The results of this pilot study suggest that midodrine and combination with tolvaptan better controls ascites without any renal or hepatic dysfunction. The combination therapy rapidly controls ascites as compared to midodrine or tolvaptan alone.